COTINGA PHARMA Revenue, Profits - COTQF Quarterly Income Statement

Add to My Stocks
$0.14 $0 (0%) COTQF stock closing price Sep 20, 2018 (Closing)

Financial analysis of COTINGA PHARMA involves more than just checking the COTINGA PHARMA stock price, by looking at the financial statements of the company in detail. The key financial statements of a company are the income statement, the balance sheet and the cash flow statement. The income statement for COTQF which shows a YOY revenue decline of 0 is specific to a period of time. Investors typically check YoY or QoQ revenue growth. Along with COTINGA PHARMA assets and COTINGA PHARMA free cash flow, COTINGA PHARMA profits as shown in profit and loss statement give key insights about the business. The net profit for 2018 Q4 is $-1.24M and the 2018 Q4 revenue is $-.

View and download details of revenue and profits for COTINGA PHARMA for latest & last 40 quarters.
show more
View Previous Quarters
View Next Quarters
Fiscal year is May - Apr2018 Q42018 Q32018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q3
COTINGA PHARMA Revenues or Net Sales
Cost Of Goods Sold (COGS)----------
Research & Development Expense----------
Selling General & Admin Expense-----1.01M----
Income Before Depreciation Depletion Amortization--1.11M-1.41M-1.15M-1.4M-1.52M-1.32M-1.02M-0.78M-0.72M
Depreciation Depletion Amortization----------
Non Operating Income---0.01M--0.04M---0.75M-0.99M-
Interest Expense----------
Provision for Income Taxes----------
Investment Gains Losses----------
Other Income----------
Income Before Extraordinaries & Disc Operations-1.24M-1.01M-1.43M-0.18M-1.43M-0.9M-0.57M-1.79M-1.84M-0.48M
Extraordinary Items & Discontinued Operations----------
COTINGA PHARMA Profit/ Loss (Net Income)
Average Shares used to compute Diluted EPS15.97M16.69M15.6M-14.67M12M14.86M14.69M13.39M12.79M
Average Shares used to compute Basic EPS15.97M16.69M15.6M-14.67M12M14.86M14.69M13.39M12.79M
Income Before Nonrecurring Items-1.24M-1.01M-1.43M--1.43M-0.9M-0.57M-1.79M-1.84M-0.48M
Income from Nonrecurring Items----------
COTINGA PHARMA Earnings Per Share Basic Net
COTINGA PHARMA Earnings Per Share Diluted Net
EPS Diluted Before Nonrecurring Items-0.08-0.06-0.09--0.10-0.10-0.10-0.10-0.10-0.10
Preferred Dividends Acc Pd----------
Dividends Common0.000.00--------
Dividend Per Share Common0.
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Quarters
View Next Quarters

Click here to view our Intrexon financial analysis

Before investing one should read a report on COTINGA PHARMA stock analysis. It helps to look at the following income statement items:

  • Topline: A growing topline, as seen from the COTINGA PHARMA revenue chart, as isn't the case with COTINGA PHARMA indicates a sagging business. One needs to compare the QoQ topline or sales growth of COTQF stock with its peers like CXRXD stock and BINDQ stock to see if the growth compares well with what can be expected from a company in that industry.
  • Bottom line: This refers to the last line in a profit and loss statement and denotes the net profit or loss for a particular period. The figure currently stands at $-1.24M for COTINGA PHARMA for 2018 Q4. This figure is arrived at after deducting all operating expenses, interest, and taxes from revenue.

The income statement is also called the profit and loss statement. Apart from the COTQF income statement, one can check the COTINGA PHARMA historical stock prices to check how the price has moved with time.

COTINGA PHARMA Income Statement - Key Financial Ratios